Please ensure Javascript is enabled for purposes of website accessibility

McCuan named director of education and outreach by JA of Central Md.

LaRee McCuan

LaRee McCuan has joined Junior Achievement of Central Maryland as director of education and outreach. In addition to overseeing the implementation of the new JA Finance Park Virtual middle school personal economics education program, McCuan helps oversee in-school elementary and high school programming, and the JA BizTown elementary school capstone program. She also serves as a liaison with higher education institutions and represents Junior Achievement with coalitions and provider networks. Most recently, she managed United Way Youth Ventures, a regional youth engagement program of the United Way of Central Maryland’s Impact Strategies Division. McCuan serves as a Riverside Neighborhood Association executive board member overseeing communications, and as a Mid-Atlantic Pug Rescue outreach coordinator. She has a master’s degree in social work from the University of Maryland, Baltimore.


Theresa A. McKenna has joined Howard Bank as assistant branch manager at the Hickory Ridge branch in Columbia. McKenna was previously a financial sales consultant at PNC in Marriottsville. She has also worked at BB&T in Charlottesville, Va., as a financial center leader and owned a store in Key West, Fla.

Health Care

Patricia Zilliox has been appointed chief drug development officer of the Foundation Fighting Blindness, based in Columbia, a national nonprofit dedicated to advancing sight-saving research for retinal degenerative diseases. She had been a consultant to the foundation since May 2011. Zilliox will be responsible for overseeing the planning and execution of clinical trials through the foundation’s National Eye and Evaluation Research Network, as well as partnering with institutions and companies around the world to advance promising treatments to patients affected with blinding diseases. She previously was senior director of clinical development pharma at Alcon Laboratories, a division of Novartis. Zilliox also is vice president of the French-American Chamber of Commerce.


Kate Hendrickson has been hired as media relations manager of the National Aquarium, of Baltimore. She previously was a social influence specialist for Planit. Hendrickson spent three years at the Port Discovery Museum, serving as the public relations and marketing coordinator and, more recently, as the public relations and events specialist. She has been a Volunteer Baltimore Certified Tourism Ambassador since 2009, and a Baltimore Tourism Association member and a Visit Baltimore GLBT Tourism Advisory Committee member.

Glenn E. Dorris Jr. has been appointed administrative and operations director of Baltimore Reads. Dorris most recently was director of sales and administration for America Works of Maryland. He has also served as operations manager of Staffmark; customer service advocate at MBNA; sales representative for Copyworld Business Systems; and as operations manager for two restaurants—Phillips and UNOs. Dorris has a bachelor’s degree from Towson University.

Nellie Power has been named assistant executive director of family and children services at The Arc Baltimore. She most recently was program director of the Baltimore Child and Adolescent Crises Response System for Catholic Charities. Before that, Power was assistant director of Catholic Charities’ Department of Community Resources. She has also been a clinical supervisor and senior mental health therapist in child and adolescent psychiatry at Johns Hopkins Bayview Medical Center, and an adjunct professor at Towson University. Power is an advisory board member of Grandparent Family Connections and a founding member of the Baltimore City DSS Mobile Crisis Stabilization Steering Committee.


Zyngenia, a biopharmaceutical company in Gaithersburg that is developing the next generation of antibody-based drugs called Zybodies, recently promoted David M. Hilbert to chief scientific officer and appointed Daniel L. Menichella as chief business officer. Hilbert joined Zyngenia in 2009 as vice president, research and development. From 2006 to 2009, he was a consultant, in assisting startup biotechnology companies. From 2004 to 2005, he was vice president of research at Cellective Therapeutics. Previously, Hilbert spent eight years at Human Genome Sciences, most recently as vice president, research. Before that, he was a staff fellow in the National Cancer Institute of the National Institutes of Health. Before joining Zyngenia, Menichella was senior vice president of corporate development and strategy at Talecris Biotherapeutics. He has served in various capacities related to business development, strategic planning and alliance management at Merck KGaA, including as a vice president. Before that he was president of MorphoSys USA and senior vice president of MorphoSys AG.